Literature DB >> 7922047

Prognostic variables in patients with gastrointestinal carcinoid tumours.

E W McDermott1, B Guduric, M F Brennan.   

Abstract

Prognostic variables in patients with gastrointestinal carcinoid tumour were studied with a view to identifying those most likely to benefit from aggressive therapy. A total of 188 patients were studied; the median follow-up of those surviving was 72 months. On univariate analysis variables of prognostic significance were sex (P < 0.01), site of the primary tumour (P < 0.01), depth of invasion (P < 0.001), tumour size (P < 0.005), presence of lymph node (P < 0.001) or liver (P < 0.001) metastases, mode of discovery (P < 0.001) and operative intent (P < 0.001). On multivariate analysis the variables independently predictive of death from disease were sex (women have a better prognosis) and presence of metastases at the time of diagnosis.

Entities:  

Mesh:

Year:  1994        PMID: 7922047     DOI: 10.1002/bjs.1800810725

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  26 in total

1.  Palliative management strategies of advanced gastrointestinal carcinoid neoplasms.

Authors:  Paola Sartori; Chiara Mussi; Carlo Angelini; Stefano Crippa; Roberto Caprotti; Franco Uggeri
Journal:  Langenbecks Arch Surg       Date:  2005-06-21       Impact factor: 3.445

2.  Gastrointestinal carcinoids: characterization by site of origin and hormone production.

Authors:  M W Onaitis; P M Kirshbom; T Z Hayward; F J Quayle; J M Feldman; H F Seigler; D S Tyler
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

Review 3.  Liver transplantation for malignancies.

Authors:  Bijan Eghtesad; Federico Aucejo
Journal:  J Gastrointest Cancer       Date:  2014-09

Review 4.  Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.

Authors:  Magaly Zappa; Mohamed Abdel-Rehim; Olivia Hentic; Marie-Pierre Vullierme; Philippe Ruszniewski; Valérie Vilgrain
Journal:  Target Oncol       Date:  2012-05-22       Impact factor: 4.493

5.  Evaluation of chromogranin A determined by three different procedures in patients with benign diseases, neuroendocrine tumors and other malignancies.

Authors:  Rafael Molina; Elias Alvarez; Angeles Aniel-Quiroga; Maria Borque; Belen Candás; Antonio Leon; Rafael M Poyatos; Montserrat Gelabert
Journal:  Tumour Biol       Date:  2010-08-21

6.  Clinical efficacy of video-assisted gasless transanal endoscopic microsurgery (TEM) for rectal carcinoid tumor.

Authors:  Y Araki; H Isomoto; K Shirouzu
Journal:  Surg Endosc       Date:  2000-12-12       Impact factor: 4.584

7.  Neuroendocrine tumor of gallbladder with liver and retroperitoneal metastases and a good response to the chemotherapeutical treatment.

Authors:  Liliana Chiorean; Adrian Bartos; Doris Pelau; Dana Iancu; Tudor Ciuleanu; Rares Buiga; Irinel Oancea; Angelica Mangrau; Cornel Iancu; Radu Badea
Journal:  J Med Ultrason (2001)       Date:  2014-10-25       Impact factor: 1.314

Review 8.  Carcinoid tumors.

Authors:  Scott N Pinchot; Kyle Holen; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2008-12-17

9.  Hepatic neuroendocrine metastases: chemo- or bland embolization?

Authors:  Susan C Pitt; Jaime Knuth; James M Keily; John C McDermott; Sharon M Weber; Hebert Chen; William S Rilling; Edward J Quebbeman; David M Agarwal; Henry A Pitt
Journal:  J Gastrointest Surg       Date:  2008-08-16       Impact factor: 3.452

10.  A Novel Nomogram to Predict the Prognosis of Patients Undergoing Liver Resection for Neuroendocrine Liver Metastasis: an Analysis of the Italian Neuroendocrine Liver Metastasis Database.

Authors:  Andrea Ruzzenente; Fabio Bagante; Francesca Bertuzzo; Luca Aldrighetti; Giorgio Ercolani; Felice Giuliante; Alessandro Ferrero; Guido Torzilli; Gian Luca Grazi; Francesca Ratti; Alessandro Cucchetti; Agostino M De Rose; Nadia Russolillo; Matteo Cimino; Pasquale Perri; Ivana Cataldo; Aldo Scarpa; Alfredo Guglielmi; Calogero Iacono
Journal:  J Gastrointest Surg       Date:  2016-08-08       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.